Artificial intelligence (AI) is not new to the pharmaceutical world; nearly 79% of biopharma companies surveyed by Citeline are either testing or using an established combination of humans
Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the most significant wave of innovation hitting the content world in life sciences, and rightly so
As the landscape of healthcare changes, so too must the way that we interpret and measure performance and success. This is particularly evident in marketing.
The world is re-balancing but the pharmaceutical industry’s engagement with HCPs has been tilted on its axis sending time-honoured engagement tactics into disarray.
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho